BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

393 related articles for article (PubMed ID: 24382281)

  • 1. Neuropsychiatric manifestations in a consecutive cohort of systemic lupus erythematosus; a single center study.
    Abdul-Sattar AB; Goda T; Negm MG
    Int J Rheum Dis; 2013 Dec; 16(6):715-23. PubMed ID: 24382281
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Neuropsychiatric manifestations in systemic lupus erythematosus: prevalence and association with antiphospholipid antibodies.
    Sanna G; Bertolaccini ML; Cuadrado MJ; Laing H; Khamashta MA; Mathieu A; Hughes GR
    J Rheumatol; 2003 May; 30(5):985-92. PubMed ID: 12734893
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Neuropsychiatric manifestations and their clinical associations in southern Chinese patients with systemic lupus erythematosus.
    Mok CC; Lau CS; Wong RW
    J Rheumatol; 2001 Apr; 28(4):766-71. PubMed ID: 11327248
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Factors and comorbidities associated with first neuropsychiatric event in systemic lupus erythematosus: does a risk profile exist? A large multicentre retrospective cross-sectional study on 959 Italian patients.
    Govoni M; Bombardieri S; Bortoluzzi A; Caniatti L; Casu C; Conti F; De Vita S; Doria A; Farina I; Ferraccioli G; Gremese E; Mansutti E; Mosca M; Padovan M; Piga M; Tincani A; Tola MR; Tomietto P; Taglietti M; Trotta F; Valesini G; Zen M; Mathieu A;
    Rheumatology (Oxford); 2012 Jan; 51(1):157-68. PubMed ID: 22075066
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Predictors of neuropsychiatric damage in systemic lupus erythematosus: data from the Maryland lupus cohort.
    Mikdashi J; Handwerger B
    Rheumatology (Oxford); 2004 Dec; 43(12):1555-60. PubMed ID: 15342927
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The prevalence of anticardiolipin antibody in patients with systemic lupus erythematosus and its association with clinical manifestations.
    Basiri Z; Gholyaf M; Faridnia M; Nadi E; Bairanvand M
    Acta Med Iran; 2013; 51(1):35-40. PubMed ID: 23456582
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Neuropsychiatric syndromes in patients with systemic lupus erythematosus and primary Sjögren syndrome: a comparative population-based study.
    Harboe E; Tjensvoll AB; Maroni S; Gøransson LG; Greve OJ; Beyer MK; Herigstad A; Kvaløy JT; Omdal R
    Ann Rheum Dis; 2009 Oct; 68(10):1541-6. PubMed ID: 18930990
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Factors at diagnosis predict subsequent occurrence of seizures in systemic lupus erythematosus.
    Mikdashi J; Krumholz A; Handwerger B
    Neurology; 2005 Jun; 64(12):2102-7. PubMed ID: 15985581
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Factors and comorbidities associated with central nervous system involvement in systemic lupus erythematosus: a retrospective cross-sectional case-control study from a single center.
    Padovan M; Castellino G; Bortoluzzi A; Caniatti L; Trotta F; Govoni M
    Rheumatol Int; 2012 Jan; 32(1):129-35. PubMed ID: 20676648
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Neuropsychological assessment in systemic lupus erythematosus patients: clinical usefulness of first-choice diagnostic tests in detecting cognitive impairment and preliminary diagnosis of neuropsychiatric lupus.
    Nowicka-Sauer K; Czuszynska Z; Smolenska Z; Siebert J
    Clin Exp Rheumatol; 2011; 29(2):299-306. PubMed ID: 21418780
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Neuropsychiatric manifestations and antiphospholipid antibodies in pediatric onset lupus: 14 years of experience from a tertiary center of North India.
    Singh S; Gupta MK; Ahluwalia J; Singh P; Malhi P
    Rheumatol Int; 2009 Oct; 29(12):1455-61. PubMed ID: 19306097
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Neuropsychiatric manifestations in patients with systemic lupus erythematosus: epidemiology and radiology pointing to an immune-mediated cause.
    Steup-Beekman GM; Zirkzee EJ; Cohen D; Gahrmann BM; Emmer BJ; Steens SC; Bollen EL; van Buchem MA; Huizinga TW
    Ann Rheum Dis; 2013 Apr; 72 Suppl 2():ii76-9. PubMed ID: 23253914
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Electroencephalography in the assessment of neuropsychiatric manifestations in antiphospholipid syndrome and systemic lupus erythematosus.
    Lampropoulos CE; Koutroumanidis M; Reynolds PP; Manidakis I; Hughes GR; D'Cruz DP
    Arthritis Rheum; 2005 Mar; 52(3):841-6. PubMed ID: 15751063
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Development and validation of a new algorithm for attribution of neuropsychiatric events in systemic lupus erythematosus.
    Bortoluzzi A; Scirè CA; Bombardieri S; Caniatti L; Conti F; De Vita S; Doria A; Ferraccioli G; Gremese E; Mansutti E; Mathieu A; Mosca M; Padovan M; Piga M; Tincani A; Tola MR; Tomietto P; Valesini G; Zen M; Govoni M;
    Rheumatology (Oxford); 2015 May; 54(5):891-8. PubMed ID: 25339643
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Neuropsychiatric events in systemic lupus erythematosus: attribution and clinical significance.
    Hanly JG; McCurdy G; Fougere L; Douglas JA; Thompson K
    J Rheumatol; 2004 Nov; 31(11):2156-62. PubMed ID: 15517627
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Plasma catecholamine metabolite levels and the activities of psychiatric symptoms in systemic lupus erythematosus.
    Ikenouchi-Sugita A; Yoshimura R; Hori H; Umene-Nakano W; Katsuki A; Saito K; Tanaka Y; Nakamura J
    Hum Psychopharmacol; 2013 Mar; 28(2):198-202. PubMed ID: 23532751
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Psychiatric and neuropsychological manifestations of systemic lupus erythematosus.
    Fietta P; Fietta P; Delsante G
    Acta Biomed; 2011 Aug; 82(2):97-114. PubMed ID: 22480065
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Long-term outcome of early neuropsychiatric events due to active disease in systemic lupus erythematosus.
    Wang M; Gladman DD; Ibañez D; Urowitz MB
    Arthritis Care Res (Hoboken); 2012 Jun; 64(6):833-7. PubMed ID: 22290935
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Serum brain-derived neurotrophic factor levels as a novel biological marker for the activities of psychiatric symptoms in systemic lupus erythematosus.
    Ikenouchi-Sugita A; Yoshimura R; Okamoto T; Umene-Nakano W; Ueda N; Hori H; Katsuki A; Saito K; Tanaka Y; Nakamura J
    World J Biol Psychiatry; 2010 Mar; 11(2):121-8. PubMed ID: 20109107
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Anti-NR2 glutamate receptor antibodies and cognitive function in systemic lupus erythematosus.
    Hanly JG; Robichaud J; Fisk JD
    J Rheumatol; 2006 Aug; 33(8):1553-8. PubMed ID: 16881112
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 20.